The Addition of Omnigel Maxstrong Enhances Omnigel's Portfolio

News Desk, News Nation 360: With the introduction of its first sub-brand, Omnigel Maxstrong, which is designed to provide targeted, long-lasting relief for people managing recurrent muscle and joint discomfort from active daily routines, Omnigel, Cipla Health's flagship pain relief brand, has formally entered the rapidly developing 2% diclofenac topical category. This premium expansion, which was unveiled in Kolkata on July 6, 2026, features a highly concentrated 5X Action formulation that greatly improves the effectiveness of local pain treatment, enabling users to maintain normal physical movement with no interference. In order to commemorate this strategic milestone, the company unveiled a modern, high-end visual rebranding that maintains its iconic red colour scheme to guarantee long-term customer continuity. Additionally, the company expanded format options across multiple preferences with the immediate commercial launch of a 30-gram topical gel and adaptable spray canisters that are available in 35-gram, 55-gram, 75-gram, and 100-gram versions across retail and e-commerce networks.